Back to Search
Start Over
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study.
- Source :
- British Journal of Haematology; Feb2019, Vol. 184 Issue 4, p660-663, 4p, 1 Diagram, 1 Chart
- Publication Year :
- 2019
-
Abstract
- The article offers information on a study related to second-line, subsequent therapy and outcomes for follicular lymphoma (FL) in U.S. Topics discussed include data taken the observational National LymphoCare Study; quarterly observations regarding disease characteristics, subsequent therapies and observed responses; and frequent utilization of rituximab in second and subsequent treatments.
- Subjects :
- RITUXIMAB
LYMPHOMAS
PROGRESSION-free survival
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 184
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 134466106
- Full Text :
- https://doi.org/10.1111/bjh.15149